UPF1 Is Crucial for the Infectivity of Human Immunodeficiency Virus Type 1 Progeny Virions

被引:41
|
作者
Serquina, Anna Kristina P. [1 ]
Das, Suman R. [1 ]
Popova, Elena [1 ]
Ojelabi, Ogooluwa A. [2 ]
Roy, Christian K. [2 ]
Goettlinger, Heinrich G. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Program Mol Med, Program Gene Funct & Express, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA
关键词
MESSENGER-RNA DECAY; ROUS-SARCOMA-VIRUS; MAMMALIAN TRANSCRIPTS; HIV-1; REPLICATION; DIVERSE CLASSES; MOV10; PROTEIN; IDENTIFICATION; COMPLEX; STABILITY; PARTICLES;
D O I
10.1128/JVI.00925-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The SF1 helicase MOV10 is an antiviral factor that is incorporated into human immunodeficiency virus type 1 (HIV-1) virions. We now report that HIV-1 virions also incorporate UPF1, which belongs to the same SF1 helicase subfamily as MOV10 and functions in the nonsense-mediated decay (NMD) pathway. Unlike ectopic MOV10, the overexpression of UPF1 does not impair the infectivity of HIV-1 progeny virions. However, UPF1 becomes a potent inhibitor of HIV-1 progeny virion infectivity when residues required for its helicase activity are mutated. In contrast, equivalent mutations abolish the antiviral activity of MOV10. Importantly, cells depleted of endogenous UPF1, but not of another NMD core component, produce HIV-1 virions of substantially lower specific infectivity. The defect is at the level of reverse transcription, the same stage of the HIV-1 life cycle inhibited by ectopic MOV10. Thus, whereas ectopic MOV10 restricts HIV-1 replication, the related UPF1 helicase functions as a cofactor at an early postentry step.
引用
收藏
页码:8853 / 8861
页数:9
相关论文
共 50 条
  • [1] UPF1 involvement in nuclear functions
    Varsally, Wazeer
    Brogna, Saverio
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 778 - 783
  • [2] UPF1: a potential biomarker in human cancers
    Chen, Bin-Lie
    Wang, Huai-Ming
    Lin, Xiao-Sheng
    Zeng, Yong-Ming
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2021, 26 (05): : 76 - 84
  • [3] UPF1 A leader at the end of chromosomes
    Azzalin, Claus M.
    NUCLEUS, 2012, 3 (01) : 16 - 21
  • [4] A cytopathic infectivity assay of human immunodeficiency virus type 1 in human primary macrophages
    Wu, SC
    Spouge, JL
    Merges, MJ
    Conley, SR
    Nara, PL
    JOURNAL OF VIROLOGICAL METHODS, 1996, 59 (1-2) : 45 - 55
  • [5] Effect of electrical stimulation on human immunodeficiency virus type-1 infectivity
    Kumagai, Etsuko
    Tominaga, Masato
    Nagaishi, Shouichiro
    Harada, Shinji
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2007, 77 (04) : 947 - 953
  • [6] Mutations in the Thumb Allow Human Immunodeficiency Virus Type 1 Reverse Transcriptase To Be Cleaved by Protease in Virions
    Dunn, Linda L.
    McWilliams, Mary Jane
    Das, Kalyan
    Arnold, Eddy
    Hughes, Stephen H.
    JOURNAL OF VIROLOGY, 2009, 83 (23) : 12336 - 12344
  • [7] Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity
    Yamashita, Tomoki
    Nomaguchi, Masako
    Miyake, Ariko
    Uchiyama, Tsuneo
    Adachi, Akio
    MICROBES AND INFECTION, 2010, 12 (02) : 166 - 171
  • [8] UPF1 Learns to Relax and Unwind
    Gleghorn, Michael L.
    Maquat, Lynne E.
    MOLECULAR CELL, 2011, 41 (06) : 621 - 623
  • [9] Plaque hybridization assay for quantifying and cloning infectious human immunodeficiency virus type 1 virions
    Kato, S
    Hiraishi, Y
    Nishimura, N
    Sugita, T
    Tomihama, M
    Takano, T
    JOURNAL OF VIROLOGICAL METHODS, 1998, 72 (01) : 1 - 7
  • [10] Functional characterization of Upf1 targets in Schizosaccharomyces pombe
    Matia-Gonzalez, Ana M.
    Hasan, Ayesha
    Moe, Goril H.
    Mata, Juan
    Rodriguez-Gabriel, Miguel A.
    RNA BIOLOGY, 2013, 10 (06) : 1057 - 1065